These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37393600)

  • 21. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.
    Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal T; Raimond L; Vistisen D; Nørgaard K
    Diabetologia; 2021 Dec; 64(12):2713-2724. PubMed ID: 34495375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: A subgroup analysis from the FLASH-UK study.
    Leelarathna L; Sutton CJ; Evans ML; Neupane S; Rayman G; Lumley S; Cranston I; Narendran P; Krishan A; Taxiarchi VP; Barnard-Kelly K; Elliott RA; Burns M; Camm M; Thabit H; Wilmot EG;
    Diabet Med; 2024 Mar; 41(3):e15249. PubMed ID: 37897112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of intermittently scanned continuous glucose monitoring on quality of life and glycaemic control in persons with type 1 diabetes: A 12-month follow-up study in real life.
    Duarte DB; Fonseca L; Santos T; Silva VB; Puga FM; Saraiva M; Silva IL; Teixeira S; Vilaverde J; Cardoso MH
    Diabetes Metab Syndr; 2022 Jun; 16(6):102509. PubMed ID: 35598543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.
    Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
    Lancet; 2021 Jun; 397(10291):2275-2283. PubMed ID: 34089660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
    Moser O; Riddell MC; Eckstein ML; Adolfsson P; Rabasa-Lhoret R; van den Boom L; Gillard P; Nørgaard K; Oliver NS; Zaharieva DP; Battelino T; de Beaufort C; Bergenstal RM; Buckingham B; Cengiz E; Deeb A; Heise T; Heller S; Kowalski AJ; Leelarathna L; Mathieu C; Stettler C; Tauschmann M; Thabit H; Wilmot EG; Sourij H; Smart CE; Jacobs PG; Bracken RM; Mader JK
    Pediatr Diabetes; 2020 Dec; 21(8):1375-1393. PubMed ID: 33047481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial.
    Ajjan RA; Heller SR; Everett CC; Vargas-Palacios A; Higham R; Sharples L; Gorog DA; Rogers A; Reynolds C; Fernandez C; Rodrigues P; Sathyapalan T; Storey RF; Stocken DD
    Diabetes Care; 2023 Feb; 46(2):441-449. PubMed ID: 36516054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protocol for a Randomized, Crossover Trial to Decrease Time in Hypoglycemia by Combined Intervention of the Usage of Intermittent-Scanning Continuous Glucose Monitoring Device and the Structured Education Regarding its Usage: Effect of Intermittent-Scanning Continuous Glucose Monitoring to Glycemic Control Including Hypoglycemia and Quality of Life of Patients with Type 1 Diabetes Mellitus Study (ISCHIA Study).
    Suzuki S; Tone A; Murata T; Nishimura K; Miyamoto Y; Sakane N; Satoh-Asahara N; Toyoda M; Hirota Y; Matsuhisa M; Kuroda A; Kato K; Kouyama R; Miura J; Suganuma A; Tomita T; Noguchi M; Son C; Kasahara M; Ito Y; Kasama S; Hosoda K
    Tokai J Exp Clin Med; 2021 Jul; 46(2):59-68. PubMed ID: 34216477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study.
    Rotondi MA; Wong O; Riddell M; Perkins B
    Diabetes Care; 2022 Sep; 45(9):2012-2019. PubMed ID: 35834175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study.
    Farrell CM; McNeilly AD; Hapca S; Fournier PA; Jones TW; Facchinetti A; Cappon G; West DJ; McCrimmon RJ
    Diabetologia; 2024 Feb; 67(2):392-402. PubMed ID: 38010533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study protocol for optimising glycaemic control in type 1 diabetes treated with multiple daily insulin injections: intermittently scanned continuous glucose monitoring, carbohydrate counting with automated bolus calculation, or both? A randomised controlled trial.
    Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal TP; Dørflinger L; Vistisen D; Nørgaard K
    BMJ Open; 2020 Apr; 10(4):e036474. PubMed ID: 32345699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation research: a protocol for two three-arm pragmatic randomised controlled trials on continuous glucose monitoring devices in people with type 1 diabetes in South Africa and Kenya.
    Marbán-Castro E; Muhwava L; Kamau Y; Safary E; Rheeder P; Karsas M; Kemp T; Freitas J; Carrihill M; Dave J; Katambo D; Kimetto J; Allie R; ; ; Ndungu J; Sigwebela N; Akach D; Girdwood S; Erkosar B; Nichols BE; Haldane C; Vetter B; Shilton S
    Trials; 2024 May; 25(1):331. PubMed ID: 38773658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parental experiences of short term supported use of a do-it-yourself continuous glucose monitor (DIYrtCGM): A qualitative study.
    Crocket H; Elbashy MM; Kavanagh T; Styles S; Galland B; Haszard JJ; Wiltshire E; Jefferies C; de Bock MI; Tomlinson P; Jones S; Wheeler BJ
    Diabet Med; 2022 May; 39(5):e14731. PubMed ID: 34687240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
    Reddy M; Jugnee N; Anantharaja S; Oliver N
    Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of Android artificial pancreas system use at home among adults with type 1 diabetes mellitus in China: protocol of a 26-week, free-living, randomised, open-label, two-arm, two-phase, crossover trial.
    Lei M; Lin B; Ling P; Liu Z; Yang D; Deng H; Yang X; Lv J; Xu W; Yan J
    BMJ Open; 2023 Aug; 13(8):e073263. PubMed ID: 37558445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittently scanned continuous glucose monitoring is associated with high satisfaction but increased HbA1c and weight in well-controlled youth with type 1 diabetes.
    Charleer S; Gillard P; Vandoorne E; Cammaerts K; Mathieu C; Casteels K
    Pediatr Diabetes; 2020 Dec; 21(8):1465-1474. PubMed ID: 32981187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients' and caregivers' experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study.
    Lawton J; Blackburn M; Allen J; Campbell F; Elleri D; Leelarathna L; Rankin D; Tauschmann M; Thabit H; Hovorka R
    BMC Endocr Disord; 2018 Feb; 18(1):12. PubMed ID: 29458348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
    Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating the cost-effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England.
    Elliott RA; Rogers G; Evans ML; Neupane S; Rayman G; Lumley S; Cranston I; Narendran P; Sutton CJ; Taxiarchi VP; Burns M; Thabit H; Wilmot EG; Leelarathna L;
    Diabet Med; 2024 Mar; 41(3):e15232. PubMed ID: 37750427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.